Granules India gets tentative USFDA nod for generic version of Mucinex ER Tablets Medical Dialogues Bureau15 Feb 2020 5:30 AM GMTNew Delhi: Drugmaker Granules India Limited recently announced that the company has received tentative approval from the US Food & Drug...
Granules India gets 2 USFDA observations for Chantilly facility Medical Dialogues Bureau23 Aug 2019 6:16 AM GMT"The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets Medical Dialogues Bureau7 Aug 2019 4:00 AM GMTAmphetamine Sulfate tablets is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.New Delhi: Drug firm...
Granules India completes USFDA inspection for Bonthapally facility with one observation Farhat Nasim29 July 2019 4:30 AM GMTGranules India Ltd's Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plant by volume. New Delhi: Drug...
Granules India Q1 net profit up 41 percent to Rs 51.7 crore Ruby Khatun Khatun25 July 2018 4:30 AM GMTNew Delhi: Drug firm Granules India reported a 40.73 percent rise in its consolidated net profit at Rs 51.79 crore for the quarter ended on June 30,...
Granules India posts Q2 net profit at Rs 40 crore Ruby Khatun Khatun10 Nov 2017 5:17 AM GMTNew Delhi: Pharma company Granules India reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current...
Granules India gets EIR from USFDA for Vizag OmniChem facility Ruby Khatun Khatun8 Oct 2017 4:31 AM GMTNew Delhi: Drug firm Granules India said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility...
